General overview of mineralocorticoid hormone action

Pharmacology and Therapeutics

Volumn 84, Issue 3, 1999, Pages 273-326

  Agarwal, M K ^a   Mirshahi, M ^a  

^a CNRS   (France)

Author keywords

Aldosterone; Corticosteroids; Hypertension; Ion channels; Receptors; Sodium pump

Indexed keywords

15BETA,16BETA METHYLENEMEXRENONE; 18 HYDROXYCORTICOSTERONE; 7ALPHA PROPYLSPIRONOLACTONE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDOSTERONE; AMILORIDE; CANRENONE; CORTICOSTERONE; CORTICOTROPIN; DEOXYCORTICOSTERONE; DROSPIRENONE; GLUCOCORTICOID; HYDROCORTISONE; MIFEPRISTONE; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR; ONAPRISTONE; PROGESTERONE; PROMEGESTONE; SODIUM CHANNEL; SPIRONOLACTONE; STEROID; UNCLASSIFIED DRUG;

ADRENAL CORTEX; ALDOSTERONE RELEASE; CELL TRANSPORT; CELL VOLUME; ENZYME ACTIVITY; EVOLUTION; GENE EXPRESSION REGULATION; HISTOCHEMISTRY; HUMAN; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; STEROID METABOLISM; STEROIDOGENESIS; STRUCTURE ACTIVITY RELATION; ZONA GLOMERULOSA;

AMILORIDE; ANIMALS; HUMANS; IMMUNOHISTOCHEMISTRY; MINERALOCORTICOIDS; NA(+)-K(+)-EXCHANGING ATPASE; RECEPTORS, MINERALOCORTICOID; SODIUM CHANNELS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032786877     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(99)00038-8     Document Type: Review

References (564)

1. Aabo K., De C.R. Hypertension during high-dose ketoconazole treatment. a probable mineralocorticosteroid effect Lancet. ii:1987;637-638.
2. Acevedo M., Olver R.E., Ward M.R. Effect of benzamil on sheep tracheal epithelium. Exp Physiol. 76:1991;935-941.
3. Achard J.M., Bubien J.K., Benos D.J., Warnock D.G. Stretch modulates amiloride sensitivity and cation selectivity of sodium channels in human B lymphocytes. Am J Physiol. 270:1996;C224-C234.
4. Agarwal M.K. Multiple Molecular Forms of Steroid Hormone Receptors. 1977;Elsevier/North Holland, Amsterdam.
5. Agarwal M.K. Hormone Antagonists. 1982;Walter de Gruyter, Berlin.
6. Agarwal M.K. Receptor Mediated Antisteroid Action. 1987;Walter de Gruyter, Berlin.
7. Agarwal M.K. Steroid receptor structure and antihormone drug design. Biochem Pharmacol. 43:1992;2299-2306.
8. Agarwal M.K. Receptors for mammalian steroid hormones in microbes and plants. FEBS Lett. 322:1993;207-210.
9. Agarwal M.K. Perspectives in receptor mediated mineralocorticoid hormone action. Pharmacol Rev. 46:1994;67-87. a.
10. Agarwal M.K. Analysis of steroid receptor domains with the aid of antihormones. Int J Biochem. 26:1994;341-350. b.
11. Agarwal M.K. The antiglucocorticoid action of mifepristone. Pharmacol Ther. 70:1996;183-213.
12. Agarwal M.K., Cayanis E. Evidence for differences in the steroid binding domains of the glucocorticoid receptor versus the idiotype antibody. Biochem Biophys Res Commun. 136:1986;470-475.
13. Agarwal M.K., Kalimi M. Paradoxical differences in the receptor binding of two new antimineralocorticoids. Biochim Biophys Acta. 964:1988;105-112.
14. Agarwal M.K., Lazar G. Antimineralocorticoids. Renal Physiol Biochem. 14:1991;217-223.
15. Agarwal M.K., Mirshahi M. Rat lung possesses the mineralocorticoid receptor. Biochem Biophys Res Commun. 183:1992;405-410.
16. Agarwal M.K., Hainque B., Moustaid N., Lazar G. Glucocorticoid antagonists. FEBS Lett. 217:1987;221-226.
17. Agarwal M.K., Mirshahi F., Mirshahi M., Rostene W. Immunochemical detection of the mineralocorticoid receptor in rat brain. Neuroendocrinology. 58:1993;575-580.
18. Agarwal M.K., Mirshahi M., Bracq S., Jullienne A., Leblanc N., Stibon F., Guern J. Nicotiana tabacum contains a putative mineralocorticoid receptor. Biochem Biophys Res Commun. 200:1994;1230-1238.
19. Agarwal M.K., Mirshahi F., Mirshahi M., Bracq S., Chentoufi J., Hott M., Jullienne A., Marie P.J. Evidence for receptor mediated mineralocorticoid action in rat osteoblastic cells. Am J Physiol. 270(Cell Physiol 39):1996;C1088-C1095.
20. Aguilera G. Factors controlling steroid biosynthesis in the zona glomerulosa of the adrenal. J Steroid Biochem Mol Biol. 45:1993;147-151.
21. Ahmad I.C., Redmond L.J., Barnstable C.J. Developmental and tissue-specific expression of the rod photoreceptor cGMP-gated ion channel gene. Biochem Biophys Res Commun. 173:1990;463-470.
22. Ahmad I.C., Korbmacher A.S., Segal P., Cheung P., Boulpaep E.L., Barnstable C.J. Mouse cortical collecting duct cells show nonselective cation channel activity and express a gene related to the cGMP-gated rod photoreceptor channel. Proc Natl Acad Sci USA. 89:1992;10262-10266.
23. Aidley D.J., Stanfield P.R. Ion Channels. 1996;Cambridge University Press, New York.
24. + transport by aldosterone in turtle urinary bladder. J Clin Invest. 58:1976;351-358.
25. Altman T. A tale of dwarfs and drugs. brassinosteroids to the rescue Trends Genet. 14:1998;490-495.
26. Anfinsen B. The Molecular Basis of Evolution. 1959;Wiley, New York.
27. Anoveros J.G., Derfler B., Golden J.N., Hyman B.T., Corey D.P. BNaC1 and BNaC2 constitute a new family of human neuronal sodium channels related to degenerins and epithelial sodium channels. Proc Natl Acad Sci USA. 94:1997;1459-1464.
28. Aperia A.C. Regulation of sodium transport. Curr Opin Nephrol Hypertens. 4:1995;416-420.
29. Arbuckle N.D., Luisi B. A recipe for specificity. Nature Struct Biol. 2:1995;341-346.
30. Arriza J.L., Weinberger C., Cerelli G., Glaser T., Handelin B.L., Husman D.E., Evans R.M. Cloning of human mineralocorticoid receptor complementary DNA. structural and functional kinship with the glucocorticoid receptor Science. 237:1987;268-275.
31. Arriza J.L., Simerly R.B., Swanson L.W., Evans R.M. The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron. 1:1988;887-900.
32. + channel by RNA from control versus aldosterone-stimulated tissues. J Biol Chem. 267:1992;16061-16065.
33. + channel subunits. Am J Physiol. 271:1996;C605-C611.
34. +-driven flagellar motors of alkalophilic Bacillus strains by amiloride analog phenamil. J Bacteriol. 172:1990;1634-1639.
35. Avenet P. Role of amiloride-sensitive sodium channels in taste. Soc Gen Physiol Ser. 47:1992;271-279.
36. Avenet P., Lindemann B. Amiloride-blockable sodium currents in isolated taste receptor cells. J Membr Biol. 105:1988;245-255.
37. Aviv A., Gardner J. Racial differences in ion regulation and their possible links to hypertension in blacks. Hypertension. 14:1989;584-589.
38. Bara M., Guiet B.A., Durlach J. Regulation of sodium and potassium pathways by magnesium in cell membranes. Magnesium Res. 6:1993;167-177.
39. + absorption. Am J Physiol. 273:1997;G571-G585.
40. Barrington E.J.W. Hormones and Evolution. 1964;English Universities Press, London.
41. Bartter F.C. The Clinical Uses of Aldosterone Antagonists. 1960;Charles E Thomas, Springfield.
42. Bartter F.C., Forman P. The different effects of aldosterone-like steroids and hydrocortisone-like steroids on urinary secretion of potassium and acid. Metab Clin Exp. 11:1962;6-20.
43. Battle D.C., Kurtzman N.A. Syndromes of aldosterone deficiency and excess. Med Clin North Am. 67:1983;879-902.
44. Beevers D.G., Brown J.J., Ferriss J.B., Fraser R., Lever A.F., Robertson J.I. The use of spironolactone in the diagnosis and the treatment of hypertension associated with mineralocorticoid excess. Am Heart J. 86:1973;404-414.
45. Ben-Ari E.T., Garrison J.C. Regulation of angiotensinogen mRNA accumulation in rat hepatocytes. Am J Physiol. 255:1988;E70-E79.
46. Benediktsson R., Edwards C.R. Apparent mineralocorticoid excess. J Hum Hypertens. 8:1994;371-375.
47. Benos D.J. Amiloride. a molecular probe of sodium transport in tissues and cells Am J Physiol. 242:1982;C131-C145.
48. + channels. Kidney Int. 49:1996;1632-1637.
49. Bentley P.J. The toad's (Bufo marinus) lens and urinary bladder as mural membranes. a comparison Exp Eye Res. 15:1973;723-729.
50. Berger S., Cole T.J., Schmid W., Shutz G. Analysis of glucocorticoid and mineralocorticoid signalling by gene targetting. Endocr Res. 22:1996;641-652.
51. + metabolism Proc Natl Acad Sci USA. 95:1998;9424-9429.
52. Berggren L. Secretory activity in vitro of the rabbit eye ciliary processes incubated with corticosteroids, neurophyseal hormones, and ascorbic acid. Acta Ophthamol. 48:1970;284-292.
53. + exchanger in proximal cells isolated from kidney. short term regulation by glucocorticoids Am J Physiol. 253:1987;F945-F951.
54. Biglieri E.G. Spectrum of mineralocorticoid adrenocortical hypertension. Hypertension. 17:1991;251-261.
55. Binder H.J., White A., Whiting D., Hayslett J. Demonstration of specific receptors for aldosterone in cytosol of rat colon. Endocrinology. 118:1986;628-631.
56. Blair-West J.R., Coghlan J.P., Denton D.A., Goding J.R., Wintour M., Wright R.D. The control of aldosterone secretion. Recent Prog Horm Res. 19:1963;311-383.
57. Blalock A. Experimental hypertension. Physiol Rev. 20:1940;159-193.
58. Blanchouin N.E., Zenatti M., Vonarx V., Schaison G., Faisant B.A. Cortisol and testosterone. inhibitory agents of the mineralocorticoid pathway. Is there a physiopathological meaning in adrenal tumors J Steroid Biochem Metab Biol. 41:1992;823-826.
59. Bland R.D., Nielson D.W. Developmental changes in lung epithelial ion transport and liquid movement. Annu Rev Physiol. 54:1992;373-394.
60. Blaustein M.P. The interrelationship between sodium and calcium fluxes across cell membranes. Rev Physiol Biochem Pharmacol. 70:1974;33-82.
61. + channel. binding sites and channel densities Am J Physiol. 272:1997;C761-C769.
62. Bodart V., Babinski K., Ong H., Léan A.D. Comparative effect of pituitary adenylate cyclase-activating polypeptide on aldosterone secretion in normal bovine and human tumorous adrenal cells. Endocrinology. 138:1997;566-573.
63. + activated adenosine triphosphatase and active cation transport in the lens. Invest Ophthalmol Vis Sci. 4:1965;723-738.
64. Bornstein M.E., Hinson J.P., Bornstein S.R., Scherbaum W.A., Vinson G.P. Intraadrenal interactions in the regulation of adrenocortical steroid signalling. Endocr Rev. 19:1998;101-143.
65. Bose H.S., Pescovitz O.H., Miller W.L. Spontaneous feminization in a 46XX female patient with congenital lipoid adrenal hyperplasia due to a homozygous frameshift mutation in the steroidogenic acute regulatory protein. J Clin Endocrinol Metab. 82:1997;1511-1515.
66. Botchkin L.M., Mathews G. Voltage dependent sodium channels develop in rat retinal pigment epithelium cells in culture. Proc Natl Acad Sci USA. 91:1994;4564-4568.
67. + channel complex from rat lymphocytes. Am J Physiol. 269:1995;C601-C611.
68. Braley L.M., Menachery A.I., Yao T., Mortensen R.M., Williams G.H. Effect of progesterone on aldosterone secretion in rats. Endocrinology. 137:1996;4773-4778.
69. Bransome E.D. Adrenal cortex. Annu Rev Physiol. 30:1968;171-212.
70. Bravo E.L. Clinical aspects of endocrine hypertension. Med Clin North Am. 71:1987;907-920.
71. Brayden D.J., Pickels R.J., Cuthbert A.W. Ion transport in cultured epithelia from human sweat glands. comparison of normal and cystic fibrosis tissues Br J Pharmacol. 102:1991;57-64.
72. Breyer M.D., Ando Y. Hormonal signalling and regulation of salt and water transport in the collecting duct. Annu Rev Physiol. 56:1994;711-739.
73. Bridges R.J., Rummel W., Schreiner J. In vitro effects of dexamethasone on sodium transport across rat colon. J Physiol. 383:1987;69-77.
74. Brilla C.G., Pick R., Tan L.B., Janicki S., Weber K.T. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res. 67:1990;1355-1364.
75. Brodin B., Nielsen R. Small transepithelial osmotic gradients affect sodium permeability in frog skin. Pflügers Arch. 423:1993;411-417.
76. Broillet M.C., Berger A., Horisberger J.D. Early effect of aldosterone on the basolateral potassium conductance of A6 cells. Pflügers Arch. 424:1993;91-93.
77. +-ATPase studies. from protein to gene and back to protein FEBS Lett. 257:1989;1-9.
78. + channels in rat kidney medulla. Am J Physiol. 256:1989;F366-F369.
79. Brown S., Hedbys B. The effect of ouabain on the hydration of the cornea. Invest Ophthalmol Vis Sci. 4:1965;216-221.
80. Bubien J.K., Jope R.S., Warnock D.G. G-proteins modulate amiloride-sensitive sodium channels. J Biol Chem. 269:1994;17780-17783.
81. + channels by β subunit mutation Am J Physiol. 270:1996;C208-C213.
82. + channel subunits in normal and cystic fibrosis airways. Am J Physiol. 269:1995;C511-C518.
83. Burris T.P., Nawaz Z., Tsai M.J., O'Malley B.W. A nuclear hormone receptor-associated protein that inhibits transactivation by the thyroid hormone and retinoic acid receptors. Proc Natl Acad Sci USA. 92:1995;9525-9529.
84. Campbell S.E., Janicki J.S., Matsubara B.B., Weber K.T. Myocardial fibrosis in the rat with mineralocorticoid excess. Prevention of scarring by amiloride. Am J Hypertens. 6:1993;487-495.
85. Canessa C.M., Schild L., Buell G., Thorens B., Gautschi I., Horisberger J.D., Rossier B.C. Amiloride-sensitive epithelial Na channel is made of three homologous subunits. Nature (Lond). 367:1994;463-467.
86. + channel regulation. Kidney Int. 48:1995;970-984.
87. Carballeira A.J., Brown W., Fishman L.M., Trujillo D., Odell D.K. The adrenal gland of stranded whales (Kogia breviceps and Mesoplodon europaeus). morphology, hormonal contents and biosynthesis of corticosteroids Gen Comp Endocrinol. 68:1987;293-303.
88. + channels in intestinal epithelia. Am J Physiol. 266:1994;G504-G510.
89. Caron K.M., Clark B.J., Ikeda Y., Parker K.L. Steroidogenic factor 1 acts at all levels of the reproductive axis. Steroids. 62:1997;53-56.
90. Cassin S., Perks A.M. Amiloride inhibits arginine vasopressin-induced decrease in fetal lung liquid secretion. J Appl Physiol. 75:1993;1925-1929.
91. Cereijido A.P.M. Polarized distribution of cation channels in epithelial cells. Cell Physiol Biochem. 1:1991;13-23.
92. + channel by steroid hormones. EMBO J. 13:1994;2177-2181.
93. Chang E., Perlman A.J. Multiple hormones regulate angiotensinogen messenger ribonucleic acid levels in rat hepatoma cell line. Endocrinology. 121:1987;513-519.
94. Chang S.S., Grunder S., Hanukoglu A., Rösler A., Mathew P.M., Hanukoglu I., Schild L., Lu Y., Shimkets R.A., Williams C.N., Rossier B.C., Lifton R.P. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nature Genet. 12:1996;248-253.
95. Chavin W., Singley J.A. Adrenocorticoids of the goldfish, Carassius auratus L. Comp Biochem Physiol. 42:1972;547-562.
96. Chen J.D., Evans R.M. A transcriptional corepressor that interacts with nuclear hormone receptors. Nature. 377:1995;454-455.
97. Chen S.Y., Wang J., Liu W., Pearce D. Aldosterone responsiveness of A6 cells is restored by cloned rat mineralocorticoid receptor. Am J Physiol. 274(Cell Physiol 43):1998;C39-C46.
98. Cherksey B.D. Functional reconstitution of an isolated sodium channel from bovine trachea. Comp Biochem Physiol. 90:1988;771-773.
99. Cherradi N., Brandenburger Y., Capponi A.M. Mitochondrial regulation of mineralocorticoid biosynthesis by calcium and StAR protein. Eur J Endocrinol. 139:1998;249-256.
100. +-conducting ion channels in the kidney. Am J Physiol. 271:1996;C1303-C1315.
101. Civan M.M., Peterson Y.K., Sanchez T.J., Coca P.M. Potential contribution of epithelial Na+ channel to net secretion of aqueous humor. J Exp Zool. 279:1997;498-503.
102. Clapham J.C., Turner N.C. Effects of the glucocorticoid II receptor antagonist mifepristone on hypertension in the obese Zucker rat. J Pharmacol Exp Ther. 282:1997;1503-1508.
103. Clark R.B. The origin and formation of the heteroneresis. Biol Rev. 36:1961;199-236.
104. Clausen T., Everts M.E. Regulation of the Na,K-pump in skeletal muscle. Kidney Int. 35:1989;1-13.
105. Clauss W., Skadhauge E. Modulation of Na and Cl transport by mineralocorticoids. Comp Biochem Physiol. 90:1988;583-589.
106. Clauss W., Dantzer V., Skadhauge E. Aldosterone modulates electrogenic Cl secretion in the colon of the hen (Gallus domesticus). Am J Physiol. 261:1991;R1533-R1541.
107. Clayton C.J., Grosser B.I., Stevens W. The ontogeny of corticosterone and dexamethasone receptors in rat brain. Brain Res. 134:1977;445-453.
108. Clyne C.D., Zhang Y., Slutsker L., Mathis J.M., White P.C., Rainey W.E. Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements. Mol Endocrinol. 11:1997;638-649.
109. Colby H.D. Chemical suppression of steroidogenesis. Environ Health Perspect. 38:1981;119-127.
110. Cole D.F. Reduction in aqueous humour formation as caused by iodate, spirolactone, and polyphloretin phosphate. Br J Ophthalmol. 46:1962;291-303.
111. Cole D.F. Localization of ouabain-sensitive adenosine triphosphatase in ciliary epithelium. Exp Eye Res. 3:1964;72-77.
112. Conn J.W., Rovner D.R., Cohen E.L. Licorice-induced pseudo-aldosteronism. JAMA. 205:1992;80-84.
113. Conway E.J., Hingerty D. The effects of cortisone, deoxycorticocosterone, and other steroids on the active transport of sodium and potassium ions in yeast. Biochem J. 55:1953;455-458.
114. Curnow K.M., Mulatero P., Emeric-Blanchouin N., Aupetit-Faisant B., Corvol P., Pascoe L. The amino acid substitutions Ser 288 Gly and Val 320 Ala convert the cortisol producing enzyme, CYP11B1, into an aldosterone producing enzyme. Nature Struct Biol. 4:1997;32-35.
115. Cuthbert A.W., Shum W.K. Does intracellular calcium modify permeability to sodium ions? Nature. 266:1977;468-469.
116. Danzo B.J., Parrott J.A., Skinner M.K. Analysis of the steroid binding domain of rat androgen-binding protein. Endocrinology. 129:1991;690-696.
117. Daughaday W.H., Holloszy J., Mariz I.K. Binding of corticosteroids by plasma proteins. VI. The binding of cortisol and aldosterone by corticosteroid-binding globulin and by estrogen-induced binding system of plasma. J Clin Endocrinol Metab. 21:1961;53-61.
118. Davidson E.T., Devenuto F., Westphal U. Steroid-protein interactions. IX. Interaction of aldosterone with human serum proteins in competition with spirolactones and other steroids. Endocrinology. 71:1962;893-900.
119. Dawson D.C. Ionic channels and colonic salt transport. Annu Rev Physiol. 53:1991;321-339.
120. DeDuve C. The beginnings of life on earth. Am Sci. 83:1995;428-437.
121. DeKloet E.R., Reul J.M.H.M. Feedback action and tonic influence of corticosteroids on brain function. a concept arising from heterogeneity of brain receptor system Psychoneuroendocrinology. 12:1987;83-105.
122. Deschepper C.F., Flaxman M. Glucocorticoid regulation of rat diencephalon angiotensinogen production. Endocrinology. 126:1990;963-970.
123. Dhallan R.S., Macke J.P., Eddy R.L., Shows T.B., Reed R.R., Yau K.W., Nathans J. Human rod photoreceptor cGMP-gated channel. amino acid sequence, gene structure, and functional expression J Neurosci. 12:1992;3248-3256.
124. DiBattista J.A., Mehdi A.Z., Sandor T. Intestinal triamcinolone acetonide receptors of the eel (Anguilla rostrata). Gen Comp Endocrinol. 51:1983;228-238.
125. Ding C., Potter E.D., Qiu W., Coon S.L., Levine M.A., Guggino S.E. Cloning and widespread distribution of the rat rod-type cyclic nucleotide-gated cation channel. Am J Physiol. 272:1997;C1335-C1344.
126. + current in mouse salivary ducts by intracellular anions is mediated by a G protein. J Physiol. 487:1995;549-555.
127. Disser J., Hazama A., Fromter E. Some properties of sodium and chloride channels in respiratory epithelia of CF- and non CF-patients. Adv Exp Med Biol. 290:1991;133-141.
128. Djouadi F., Wijkhuisen A., Bastin J. Coordinate development of oxidative enzymes and Na,K,ATPase in thick ascending limb. role of corticosteroids Am J Physiol. 32:1992;F237-F242.
129. Dluhy R.G., Lifton R.P. Glucocorticoid-remediable aldosteronism (GRA). diagnosis, variability of phenotype and regulation of potassium homeostasis Steroids. 60:1995;48-51.
130. Doerr H.G., Sippell W.G., Versmold H.T., Bidlingmaier F., Knorr D. Plasma mineralocorticoids, glucocorticoids and progestins in premature infants. longitudinal study during the first week of life Pediatr Res. 23:1988;525-529.
131. Doolan C.M., Harvey B.J. Modulation of cytosolic protein kinase C and calcium ion activity by steroid hormones in rat distal colon. J Biol Chem. 271:1996;8763-8767.
132. Doolin R.E., Gilbertson T.A. Distribution and characterization of functional amiloride-sensitive sodium channels in rat tongue. J Gen Physiol. 107:1996;545-554.
133. + pumps in rat skeletal muscle. J Endocrinol. 152:1997;49-57.
134. Drury P.L. Disorders of mineralocorticoid activity. Clin Endocrinol Metab. 14:1985;175-202.
135. Duax W.L., Griffin J.F. Structural differences distinguishing steroid antagonists from agonists. Agarwal M.K. Receptor Mediated Antisteroid Action. 1987;1-16 Walter de Gruyter, Berlin.
136. Eaton D.C., Hamilton K.L. The amiloride-blockable sodium channel of epithelial tissues. Ion Channels. 1:1988;251-282.
137. Eaton D.C., Becchetti A., Ma H., Ling B.N. Renal sodium channels. regulation and single channel properties Kidney Int. 48:1995;941-949.
138. Edelman I.S. Mechanism of action of aldosterone. energetic and permeability factors J Endocrinol. 81:1979;49-53.
139. Egfjord M., Olgaard K. Aldosterone metabolism in the isolated, perfused liver of R and S hypertension-prone Dahl rats. Am J Physiol. 262:1992;E488-E496.
140. Ehrlich E.N. Aldosterone, the adrenal cortex, and hypertension. Annu Rev Med. 19:1968;373-398.
141. Elliott M.E., Goodfriend T.L. Mechanism of fatty acid inhibition of aldosterone synthesis by bovine adrenal glomerulosa cells. Endocrinology. 132:1993;2453-2460.
142. Ellis D., Sothi T.D., Avner E.D. Glucocorticoids modulate renal glucocorticoid receptors and Na,K,ATPase activity. Kidney Int. 32:1987;464-471.
143. Els W.J., Helman S.I. Regulation of epithelial sodium channel densities by vasopressin signalling. Cell Signal. 1:1989;533-539.
144. Ernst S.A., Hootman S.R. Microscopic methods for the localization of Na,K,ATPase. Histochem J. 13:1981;397-418.
145. +ATPase. mechanisms underlying rapid and sustained changes in pump activity Am J Physiol. 269:1995;C295-C311.
146. Fardella C.E., Miller W.L. Molecular biology of mineralocorticoid metabolism. Annu Rev Nutr. 16:1996;443-470.
147. Farnsworth W.E. Na,K-ATPase. Med Hypotheses. 41:1993;358-362.
148. - channels J Pharmacol Exp Ther. 264:1993;210-216.
149. Feigin A.M., Ninomiya Y., Bezrukov S.M., Bryant B.P., Moore P.A., Komai M., Wachowiak M., Teeter J.H., Vodyanoy I., Brand J.G. Enhancement of gustatory nerve fibers to NaCl and formation of ion channels by commercial novobiocin. Am J Physiol. 266:1994;C1165-C1172.
150. Feldman D., Couropmitree C. Intrinsic mineralocorticoid agonist activity of some nonsteroidal anti-inflammatory drugs. J Clin Invest. 57:1976;1-7.
151. Ferrini M., Magarinos A.M., De N.A. Oestrogens down-regulate type I but not type II adrenal corticoid receptors in rat anterior pituitary. J Steroid Biochem. 35:1990;671-677.
152. Feuillan P.P., Aguilera G. Regulation of aldosterone in the 7-day old rat. Endocrinology. 137:1996;3992-3998.
153. Firsov D., Gautschi I., Merillat A.M., Rossier B.C., Schild L. The heterotetrameric structure of the epithelial sodium channel (ENaC). EMBO J. 17:1998;344-352.
154. + channels in frog lung epithelium. a target tissue for aldosterone action Pflügers Arch. 416:1990;62-67.
155. Flood C., Gherandache C., Pincus O., Tait J.F., Tait S.A.S., Willoughby S. The metabolism and secretion of aldosterone in elderly subjects. J Clin Invest. 46:1967;960-966.
156. Forman B.M., Umesono K., Chen J., Evans R.M. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell. 81:1995;541-550.
157. Fraser R., Lantos C.P. 18-Hydroxycorticosterone, a review. J Steroid Biochem. 9:1978;273-286.
158. Frenkel M., Krill A.E. Effects of two mineralocorticoids on ocular tension. Arch Ophthal. 72:1964;315-318.
159. Frindt G., Silver R.B., Windhager E.E., Palmer L.G. Feedback regulation of Na channels in rat CCT. III. Response to cAMP. Am J Physiol. 268:1995;F480-F489.
160. + absorption in rat late distal colon by nanomolar aldosterone added in vitro. Am J Physiol. 264:1993;E68-E73.
161. Fujii Y., Takemoto F., Katz A.I. Early effects of aldosterone on Na-K pump in rat collecting duct tubules. Am J Physiol. 259:1990;F40-F45.
162. + channel by C-terminal truncation of the bovine subunit. J Biol Chem. 271:1996;26602-26608.
163. Funder J.W., Krozowski Z., Myles K., Sato A., Sheppard K.E., Young M. Mineralocorticoid receptors, salt, and hypertension. Rec Prog Horm Res. 52:1997;247-260.
164. Fyfe G.K., Quinn A., Canessa C.M. Structure and function of the Mec-ENaC family of ion channels. Semin Nephrol. 18:1998;138-151.
165. Gadallah M.F., Abreo K., Work J. Liddle's syndrome, an unrecognized entity. a report of four cases, including the first report in black individuals Am J Kidney Dis. 25:1995;829-835.
166. + channels by endothelin-1 in distal nephron cells. Am J Physiol. 271:1996;F451-F460.
167. Ganguly A. Atrial natriuretic peptide-induced inhibition of aldosterone secretion. a quest for mediators Am J Physiol. 263:1992;E181-E194.
168. Ganong W.F., Biglieri E.G., Murlow P.J. Mechanisms regulating adrenocortical secretion of aldosterone and glucocorticoids. Rec Prog Horm Res. 22:1966;381-414.
169. + transport abnormalities in erythrocytes from essential hypertensive patients. A first step towards the diagnosis and specific treatment of different forms of essential hypertension. Cardiovasc Drugs Ther. 2:1990;373-378.
170. Garg L.C., Narang N. Effects of aldosterone on NEM-sensitive ATPase in rabbit nephron segments. Kidney Int. 34:1988;13-17.
171. Garg L.C., Knepper M.A., Burg M.B. Mineralocorticoid effects on Na-K-ATPase in individual nephron segments. Am J Physiol. 240:1981;F536-F544.
172. + channels. FASEB J. 8:1994;522-528.
173. Garty H., Palmer L.G. Epithelial sodium channels. function, structure and regulation Physiol Rev. 77:1997;359-396.
174. Garwitz E.T., Jones A.W. Altered arterial ion transport and its reversal in aldosterone hypertensive rats. Am J Physiol. 243:1982;H927-H933.
175. Geiger H., Bahner U., Palkovits M. Effects of aldosterone and dexamethasone on atrial natriuretic peptide levels in preoptic and hypothalamic nuclei of adrenalectomized and intact rats. Neuroendocrinology. 53:1991;63-68.
176. Geller D.S., Rodriguez S.J., Vallo B.A., Schifter S., Bayer M., Chand S.S., Lifton R.P. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nat Genet. 19:1998;279-281.
177. Genard P., Palem V.P. Structure-activity relationships for agonistic and antagonistic mineralocorticoids. J Steroid Biochem. 13:1980;1299-1305.
178. Gesek F.A., Friedman P.A. Sodium entry mechanisms in distal convoluted tubule cells. Am J Physiol. 269:1995;F89-F98.
179. Gewirth D.T., Sigler P.B. The basis for half-site specificity explored through a non-cognate steroid-receptor DNA complex. Nature Struct Biol. 2:1995;386-394.
180. Gilbertson T.A., Avenet P., Kinnamon S.C., Roper S.D. Proton currents through amiloride-sensitive Na channels in hamster taste cells. role in acid transduction J Gen Physiol. 100:1992;803-824.
181. Gilbertson T.A., Roper S.D., Kinnamon S.C. Proton currents through amiloride-sensitive Na channels in hamster taste cells. enhancement by vasopressin and cAMP Neuron. 10:1993;931-942.
182. Gilmour D. The Biochemistry of Insects. 1960;Academic Press, New York.
183. Gomez-Sanchez E.P. Mineralocorticoid modulation of central control of blood pressure. Steroids. 60:1995;69-72.
184. Gordon R.D., Stowasser M., Klemm S.A., Tunny T.J. Primary aldosteronism. some genetic, morphological, and biochemical aspects of subtypes Steroids. 60:1995;35-41.
185. Graham A., Steel D.M., Wilson R., Cole P.J., Alton E.W., Geddes D.M. Effects of purified Pseudomonas rhamnolipids on bioelectric properties of sheep tracheal epithelium. Exp Lung Res. 19:1993;77-89.
186. Granitzer M., Mountian I., Van D.W. Effect of dexamethasone on sodium channel block and densities in A6 cells. Pflügers Arch. 430:1995;493-500.
187. +,ATPase of toad (Bufo marinus) kidney with basal and apical membranes of transporting epithelial of the rat. Cell Tissue Res. 258:1989;137-145.
188. Graves S.W. The sodium pump in hypertension. Curr Opin Nephrol Hypertens. 3:1994;107-111.
189. Green J., Kleeman C.R. Role of bone in regulation of systemic acid-base balance. Kidney Int. 39:1991;9-26.
190. Grekin R., Sider R.S. Aldosterone receptor measurements during changes in dietary sodium. Endocrinology. 108:1981;109-112.
191. + transport across airway epithelia. Am J Physiol. 275(Cell Physiol 44):1998;C303-C308.
192. Gründer S., Firsov D., Chang S.S., Jaeger N.F., Gautschi I., Schild L., Lifton R.P., Rossier B.C. A mutation causing pseudohypoaldosteronism type I identifies a conserved glycine that is involved in the gating of the epithelial sodium channel. EMBO J. 16:1997;899-907.
193. Grundy H.M., Simpson S.A., Tait J.F. Isolation of a highly active mineralocorticoid from beef adrenal extract. Nature. 169:1952;795-796.
194. Grünfeld J.P., Eloy L., Moura A.M., Ganeual D., Frendo B.R., Worcel M. Effects of antiglucocorticoids on glucocorticoid hypertension in the rat. Hypertension. 7:1986;292-299.
195. Guyton A.C. Blood pressure control - special role of the kidneys and body fluids. Science. 252:1991;1813-1816.
196. Hackney C.M., Furness D.N., Benos D.J., Woodley J.F., Barratt J. Putative immunolocalization of the mechanoelectrical transduction channels in mammalian cochlear hair cells. Proc R Soc Lond B: Biol Sci. 248:1992;215-221.
197. + pump in low renin hypertension. J Cardiovasc Pharmacol. 6(suppl. 2):1984;S439-S456.
198. Haigney M.C., Lakatta E.G., Stern M.D., Silverman H.S. Sodium channel blockade reduces hypoxic sodium loading and sodium-dependent calcium loading. Circulation. 90:1994;391-399.
199. Hall P.F. The role of calmodulin, actin and vimentin in steroid synthesis by adrenal cells. Steroids. 62:1997;185-189.
200. Halm D.R., Halm S.T. Aldosterone stimulates K secretion prior to onset of Na absorption in guinea pig distal colon. Am J Physiol. 266:1994;C552-C558.
201. Hampl R., Starka L., Obenberger J. Aldosterone binding in rabbit lens epithelium. Exp Eye Res. 33:1981;581-583.
202. Hampl R., Starka L., Obenberger J., Rozsival P. Content and binding of aldosterone in human ocular lens. Endocrinol Exp. 18:1984;59-64.
203. Hansson J., Schild L., Lu Y. A de novo missense mutation of the β subunit of the epithelial sodium channel causes hypertension and Liddle's syndrome and identifies a proline-rich segment of the protein critical for regulation of channel activity. Proc Natl Acad Sci USA. 92:1995;11495-11499. a.
204. Hansson J.H., Willliams C.N., Suzuki H. Hypertension caused by a truncated epithelial sodium channel γ subunit. genetic heterogeneity of Liddle's syndrome Nat Genet. 11:1995;76-80. b.
205. Harnik M., Kashman Y., Cojokaru M., Rosenthal T., Morris D.J. Synthesis of 19-noraldosterone, a potent mineralocorticoid. J Steroid Biochem. 24:1986;1163-1169.
206. Harvey B.J. Cross-talk between sodium and potassium channels in tight epithelia. Kidney Int. 48:1995;1191-1199.
207. Helman S.I., Baxendale L.M. Blocker-related changes of channel density. Analysis of a three-state model for apical Na channels of frog skin. J Gen Physiol. 95:1990;647-678.
208. Henderson I.W., Jackson B.A., Hargreaves G. Action and metabolism of corticosteroids in teleost fish. Biochem Soc Trans. 3:1975;1168-1171.
209. Henningsen N.C. The sodium pump and energy regulation. Some new aspects for essential hypertension, diabetes II and severe overweight Klin Wochenschr. 3:1985;4-8.
210. Herbet C.S. Does calcium couple the apical and basolateral membrane permeabilities in epithelia? Am J Physiol. 247:1984;F869-F876.
211. Herman J.P., Patel P.D., Akil H., Watson S.J. Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat. Mol Endocrinol. 3:1989;1886-1894.
212. Hershberger L.G., Thompson C.R. Determination of anti-aldosterone in adrenalectomized dogs. Proc Soc Exp Biol Med. 129:1968;24-26.
213. Hilbert P., Lindpainter K., Beckman J.S., Serikawa T., Soubrier F., Dubay C., Cartwright P., deGouyon B., Julier C., Takahasi S., Vincent M., Ganten D., Georges M., Lathrop G.M. Chromosomal mapping of two genetic loci associated with blood pressure regulation in hereditary hypertensive rats. Nature. 353:1991;521-529.
214. Hillyard S.D., Van D.W. Development of aldosterone-stimulation of short-circuit current across larval frog skin. J Comp Physiol. 161:1991;257-263.
215. Hilton P.J. Cellular sodium transport in essential hypertension. N Engl J Med. 314:1986;222-229.
216. Hinton C.F., Eaton D.C. Expression of amiloride-blockable sodium channels in Xenopus oocytes. Am J Physiol. 257:1989;C825-C829.
217. + by the retinal pigment epithelium during the light response. Experientia. 50:1994;438-441.
218. Holtug K., Hansen M.B., Skadhauge E. Experimental studies of intestinal ion and water transport. Scand J Gastroenterol Suppl. 216:1996;95-110.
219. Horisberger J.D., Lemas V., Kraenbuhl J.P., Rossier B.C. Structure-function relationship of Na,K-ATPase. Annu Rev Physiol. 53:1991;565-584.
220. + transport across inner medullary collecting duct by glucocorticoid and mineralocorticoid hormones. J Clin Invest. 86:1990;498-506.
221. +/ATPase gene expression in adult and neonatal cardiocytes. J Biol Chem. 266:1991;12058-12066.
222. Inoue T., Okauchi Y., Matsuzaki Y., Kuwajima K., Kondo H., Horiuchi N., Nakao K., Iwata M., Yokogoshi Y., Shintani Y., Bando H., Saito S. Identification of a single cytosine base insertion at Arg-597 of the beta subunit of the human epithelial sodium channel in a family with Liddle's disease. Eur J Endocrinol. 138:1998;691-697.
223. + channels in planar bilayers. J Biol Chem. 269:1994;22193-22197.
224. Ismailov I.I., Berdiev B.K., Shlyonsky V.G., Fuller C.M., Prat A.G., Jovov B., Cantiello H.F., Ausiello D.A., Benos D.J. Role of actin in regulation of epithelial sodium channels by CFTR. Am J Physiol. 272:1997;C1077-C1086. a.
225. + channel. J Biol Chem. 272:1997;21075-21083. b.
226. Ito M., Yu R., Jameson J.L. DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol Cell Biol. 17:1997;1476-1483.
227. Iwasa K.H., Mizuta K., Lim D.J., Benos D.J., Tachibana T. Amiloride-sensitive channels in marginal cells in the stria vascularis of the guinea pig cochlea. Neurosci Lett. 172:1994;163-166.
228. Jackson R.T., Waitzman M.B. Effects of some steroids on aqueous humor dynamics. Exp Eye Res. 4:1965;112-123.
229. Jackson S.N., Williams B., Houtman P., Trembath R.C. The diagnosis of Liddle syndrome by identification of a mutation in the beta subunit of the epithelial sodium channel. J Med Genet. 35:1998;510-512.
230. Jacob T.J.C., Civan M.M. Role of ion channels in aqueous humor formation. Am J Physiol. 271:1996;C703-C720.
231. Jalaguier S., Mornet D., Mesnier D., Leger J.J., Auzou G. Human mineralocorticoid receptor interacts with actin under mineralocorticoid ligand modulation. FEBS Lett. 384:1996;112-126.
232. James V.H.T. The Adrenal Gland. 1992;Raven Press, New York.
233. James V.H.T., Few J.D. Adrenocorticoids. chemistry, synthesis and disturbance in disease Clin Endocrinol Metab. 14:1985;867-892.
234. Jamieson A., Connell J.M., Fraser R. Glucocorticoid-suppressible hyperaldosteronism. from confusion to conclusion J Mol Endocrinol. 10:1993;3-5.
235. Janiak P.C., Lewis S.J., Brody M.J. Role of central mineralocorticoid binding sites in development of hypertension. Am J Physiol. 258:1990;R1025-R1034.
236. Jensen E.V. Remembrance. Gregory Pincus: a catalyst for early receptor studies Endocrinology. 131:1992;1581-1582.
237. Jiang C., Finkbeiner W.E., Widdicombe J.H., McCray P.J., Miller S.S. Altered fluid transport across airway epithelium in cystic fibrosis. Science. 262:1993;424-427.
238. Jorgensen P.L. Molecular basis for active Na,K-transport by Na,K-ATPase from outer renal medulla. Biochem Soc Symp. 50:1985;59-79.
239. Jorgensen P.L., Andersen J.P. Structural basis for E1-E2 conformational transitions in Na-K-pump and Ca-pump proteins. J Membr Biol. 103:1988;95-120.
240. + channel Pflügers Arch. 414:1989;369-372.
241. Kagawa C.M. Blocking the renal electrolyte effects of mineralocorticoids with an orally active spirolactone. Endocrinology. 67:1960;125-131.
242. Kageyama Y., Suzuki H., Saruta T. Role of glucocorticoid in the development of glycyrrhizin-induced hypertension. Clin Exp Hypertens. 16:1994;761-768.
243. Kalimi M. Role of antiglucocorticoid RU 486 on dexamethasone-induced hypertension in rats. Am J Physiol. 256:1989;E682-E685.
244. Kalimi M., Agarwal M.K. Interaction of antiglucocorticoid RU 486 with rat kidney glucocorticoid receptors. Biochem Biophys Res Commun. 153:1988;365-371.
245. Kalimi M., Opoku J., Agarwal M.K., Corley K. Effects of antimine ralocorticoid RU 26752 on steroid-induced hypertension in rats. Am J Physiol. 258:1990;E737-E739.
246. Kamata S., Haga N., Mitsugi T., Kondo E., Nagata W., Nakamura M., Miyata M., Odaguchi K., Shimizu T., Kawabata T., Suzuki T., Ishibashi M., Yamada F. Aldosterone antagonists. 1. Synthesis and biological activities of 11β, 18-epoxypregnane derivatives. J Med Chem. 28:1985;428-433.
247. Kaplan J.H. Ion movements through the sodium pump. Annu Rev Physiol. 47:1985;535-544.
248. Kaplan M.R., Franke A.M., Lambert S., Bennett V., Duncan I.D., Levinson S.R., Barres B.A. Induction of sodium channel clustering by oligodendrocytes. Nature. 386:1997;724-728.
249. Karlson K.H., Bates F.C., McCoy D.E., Kizer N.L., Stanton B.A. Cloning of a cGMP-gated cation channel from mouse kidney inner medullary collecting duct. Biochim Biophys Acta. 1236:1995;197-200.
250. Karlson P. The chemistry of insect hormones and pheromones. Pure Appl Chem. 14:1967;75-87.
251. Karlson P., Sekeris C.E. Ecdysone. an insect hormone, and its mode of action Rec Prog Horm Res. 22:1966;473-494.
252. Kashgarian M., Biemesderfer D., Caplan M., Forbush B. Monoclonal antibody to Na,K-ATPase. immunocytochemical localization along nephron segments Kidney Int. 28:1985;899-913.
253. Kater C.E., Biglieri E.G., Brust N., Chang B., Hirai J., Irony I. Stimulation and suppression of the mineralocorticoid hormones in normal subjects and adrenocortical disorders. Endocr Rev. 10:1989;149-164.
254. Katz A.I. Corticosteroid regulation of Na-K-ATPase along the mammalian nephron. Semin Nephrol. 10:1990;388-399.
255. Kemp P.J., Olver R.E. G protein regulation of alveolar ion channels. implications for lung fluid transport Exp Physiol. 81:1996;493-504.
256. Khimenko P.L., Barnard J.W., Moore T.M., Wilson P.S., Ballard S.T., Taylor A.E. Vascular permeability and epithelial transport effects on lung edema formation in ischemia and reperfusion. J Appl Physiol. 77:1994;111-1121.
257. Kim Y.C., Ariyoshi N., Artemenko I., Elliott M.E., Bhattacharya K.K., Jefcoate C.R. Control of cholesterol access to cytochrome P450 scc in rat adrenal cells mediated by regulation of the steroidogenic acute regulatory protein. Steroids. 62:1997;10-20.
258. Kinnamon S.C. Role of apical ion channels in sour taste transduction. Ciba Found Symp. 179:1993;201-210.
259. Kinsella J.L. Action of glucocorticoids on proximal tubule transport system. Semin Nephrol. 10:1990;330-338.
260. Kitanaka S., Katsumata N., Tanae A., Hibi I., Takeyama K., Fuse H., Kato S., Tanaka T.A. New compound heterozygous mutation in the 11 beta hydroxy-steroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess. J Clin Endocrinol Metab. 82:1997;4054-4058.
261. Kleyman T.R., Cragoe E.J. The mechanism of action of amiloride. Semin Nephrol. 8:1988;242-248.
262. + channel antibody raised by the antiidiotypic route. J Biol Chem. 266:1991;3907-3915.
263. Knowles M.R., Church N.L., Waltner W.E., Yankaskas J.R., Glligan P., King M., Edwards L.J., Helms R.W., Boucher R.C. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N Engl J Med. 322:1990;1189-1194.
264. Knox F.G., Diaz B.J. The hormonal control of sodium excretion. Int Rev Physiol. 16:1977;173-198.
265. Koch K.S., Leffert H.L. Ionic landmarks along the mitogenic route. Nature. 279:1979;104-105.
266. Koeppen B.M. Electrophysiological identification of principal and intercalated cells in the rabbit outer medullary collecting duct. Pflügers Arch. 409:1987;138-141.
267. Komwatana P., Dinudom A., Young J.A., Cook D.I. Cytosolic Na controls epithelial sodium channel via the guanine nucleotide-binding regulatory proteins. Proc Natl Acad Sci USA. 93:1996;8107-8111.
268. + channels. Steroids. 60:1995;114-119.
269. Kornel L., Nelson W.A., Manisundaram B., Chigurupati R., Hayashi T. Mechanism of the effects of glucocorticoids and mineralocorticoids on vascular smooth muscle contractility. Steroids. 58:1993;580-587.
270. Koshida H., Miyamori I., Soma R., Matsubara T., Ikeda M., Takeda R., Nakamura S., Kiuchi F., Tsuda Y. Mineralocorticoid and renal receptor binding activity of 21-deoxyaldosterone. Endocrinology. 126:1990;1410-1415.
271. Kostrouch Z., Kostrouchova M., Rall J.E. Steroid/thyroid hormone receptor genes in Caenorhabditis elegans. Proc Natl Acad Sci USA. 92:1995;156-159.
272. Krattenmacher R., Voigt R., Clauss W. Ca-sensitive sodium absorption in the colon of Xenopus laevis. J Comp Physiol B. 160:1990;161-165.
273. + conductance in cystic fibrosis Pflügers Arch. 431:1995;1-9.
274. + channel involved in sperm-induced fertilization. Science. 261:1993;484-486.
275. - transport in intercalated cells. J Clin Invest. 89:1992;1388-1394.
276. Lala D.S., Rice D.A., Parker K.L. Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of tarazu-factor I. Mol Endocrinol. 6:1992;1249-1258.
277. Lalli E., Bardoni B., Zazopoulos E., Wurtz J.M., Strom T.M., Moras D., Corsi P.S. A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenita. Mol Endocrinol. 11:1997;1950-1960.
278. Landau R.L., Lugibihl K. Inhibition of sodium retaining influence of aldosterone by progesterone. J Clin Endocrinol Metab. 18:1958;1237-1245.
279. + transport by rat collecting duct cells in culture. J Clin Invest. 90:1992;1370-1378.
280. Larsen E.H., Novak I., Pedersen P.S. Cation transport by sweat ducts in primary culture. Ionic mechanism of cholinergically evoked current oscillations. J Physiol. 424:1990;109-131.
281. Lassman M.N., Murlow P.J. Deficiency of deoxycorticosterone-binding protein in the hypothalamus of rats resistant to deoxycorticosterone-induced hypertension. Endocrinology. 94:1974;1541-1546.
282. Laudet V., Hänni C., Coll J., Catzeflis J.F., Stéhélin D. Evolution of the nuclear receptor gene superfamily. EMBO J. 11:1992;1003-1013.
283. Lazar G., Pagano M., Agarwal M.K. Purification and characterization of the activated mineralocorticoid receptor from rat kidney. Int J Biochem. 22:1990;621-630. a.
284. Lazar G., Pagano M., Agarwal M.K. Purification and characterization of the activated mineralocorticoid receptor from rat myocardium. Biochim Biophys Acta. 1033:1990;41-48. b.
285. Lazar G., Lazar G. Jr., Husztik E., Duda E., Agarwal M.K. The influence of antiglucocorticoids on stress and shock. Ann N Y Acad Sci. 761:1995;276-295.
286. Lehman H.F., Rudel R. Molecular pathophysiology of voltage-gated ion channels. Rev Physiol Biochem Pharmacol. 128:1996;195-268.
287. Lester G., Stone D., Hechtor O. The effects of deoxycorticosterone and other steroids in Neurospora crassa. Arch Biochem Biophys. 75:1958;196-214.
288. Lewis S.A., Clausen C. Urinary proteases degrade epithelial sodium channels. J Membr Biol. 122:1991;77-88.
289. Li J.J., Li S.A., Cuthbertson T.L. Nuclear retention of all steroid hormone receptor classes in the hamster renal carcinoma. Cancer Res. 39:1979;2647-2651.
290. Li X.J., Xu R.H., Guggino W.B., Snyder S.H. Alternatively spliced forms of the alpha subunit of the epithelial sodium channel. Distinct sites for binding and channel pore Mol Pharmacol. 47:1995;1133-1140.
291. Lifton R.P. Genetic determinants of human hypertension. Proc Natl Acad Sci USA. 92:1995;8545-8551.
292. Lifton R.P., Dluhy R.G., Powers M., Rich G.M., Cook S., Ulick S., Lalouel J.M. A chimaeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature. 355:1992;262-265.
293. Lindemann B. Fluctuation analysis of sodium channels in epithelia. Annu Rev Physiol. 46:1984;497-515.
294. Lindsay R., Dempster D.W., Jordan V.C. Estrogens and Antiestrogens. Basic and Clinical Aspects:1997;Lippincott-Raven, Hagerstown.
295. Ling B.N., Kemendy A.E., Kokko K.E., Hinton C.F., Marunaka Y., Eaton D.C. Regulation of the amiloride-blockable sodium channel from epithelial tissues. Mol Cell Biochem. 99:1990;141-150.
296. +-ATPase. J Biol Chem. 269:1994;19659-19662.
297. Lingrel J.B., Orlowski J., Shull M.M., Price E.M. Molecular genetics of Na,K-ATPase. Prog Nucleic Acid Res. 38:1990;37-89.
298. + channel. A new channel type with homologies to Caenorhabditis elegans degenerins. FEBS Lett. 318:1993;95-99.
299. Linner E., Wistrand P.J. Adrenal cortex and aqueous humour dynamics. Exp Eye Res. 2:1963;148-159.
300. Liu M.S. Mechanisms of myocardial membrane alterations in endotoxin shock. roles of phospholipase and phosphorylation Circ Shock. 30:1990;43-49.
301. Liu W., Wang J., Sauter N.K., Pearce D. Steroid receptor heterodimerization demonstrated in vitro and in vivo. Proc Natl Acad Sci USA. 92:1995;12480-12484.
302. Llaurado J.P., Madden J.A., Smith G.A. Some effects of aldosterone on sodium kinetics and distribution in porcine arterial wall. Am J Physiol. 244:1983;R553-R557.
303. +-ATPase. Semin Nephrol. 12:1992;62-66.
304. + conductances in rat distal colon. Am J Physiol. 267:1994;G485-G493.
305. Losert W., Stenzel J.C., Buse M. Progestogens with antimineralocorticoid activity. Drug Res. 35:1985;459-471.
306. Losert W., Bittler D., Buse M., Stenzel J.C., Haberey M., Laurent H., Nickish K., Schillinger E., Wiechert R. Mespirenone and other 15,16-methylene-17-spirolactones, a new type of steroidal aldosterone antagonists. Drug Res. 36:1986;1583-1600.
307. Ludens J., Fanestil D.D. Aldosterone stimulation of acidification of urine in isolated bladder of the Colombian toad. Am J Physiol. 226:1974;1321-1326.
308. Lupo B., Mesnier D., Auzou G. Cysteines 849 and 942 of human mineralocorticoid receptor are crucial for steroid binding. Biochemistry. 37:1998;12153-12159.
309. + channel blockers inhibit voltage-dependent intracellular pH changes in principal cells of frog (Rana pipiens) skin. Comp Biochem Physiol. 105:1993;503-511.
310. + channels in A6 distal nephron cells. Am J Physiol. 265:1996;F798-F805.
311. Macknight A.D.C., Leaf A. Regulation of cellular volume. Physiol Rev. 57:1977;510-573.
312. Macknight A.D.C., DiBona D.R., Leaf A. Sodium transport across toad urinary bladder. a model "tight" epithelium Physiol Rev. 60:1980;615-715.
313. Mahato S.B., Banarjee S., Podder S. Steroid transformations by microorganisms. Phytochemistry. 28:1989;494-497.
314. Makino K., Yasuda K., Okuyama M., Ojima M., Sasano N., Miura K. An adrenocortical tumor secreting weak mineralocorticoids. Endocrinol Jpn. 34:1987;65-72.
315. Mansfield T.A., Simon D.B., Farfel Z., Bia M., Tucci J.R., Lebel M., Gutkin M., Vialettes B., Christofilis M.A., Makelin R.K., Mayan H., Risch N., Lifton R.P. Multilocus linkage of familial hyperkalemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21. Nat Genet. 16:1997;202-205.
316. Marunaka Y., Eaton D.C. Effects of vasopressin and cAMP on single amiloride-blockable Na channels. Am J Physiol. 260:1991;C1071-C1084.
317. Marunaka Y., Hagiwara N., Tohda H. Insulin activates single amiloride-blockable Na channels in a distal nephron cell line (A6). Am J Physiol. 263:1992;F392-F400.
318. + channels in alveolar epithelial cells. Am J Physiol. 271:1996;L1-L22.
319. Mathias R.T., Rae J.L. Transport properties of the lens. Am J Physiol. 249:1985;C181-C190.
320. Matsusaka T., Ichikawa I. Biological functions of angiotensin and its receptors. Annu Rev Physiol. 59:1997;395-412.
321. +-selective channels via actin cytoskeleton modification in leukemia cells. FEBS Lett. 412:1997;94-96.
322. McCoy D.E., Guggino S.E., Stanton B.A. The renal cGMP-gated cation channel. its molecular structure and physiological role Kidney Int. 48:1995;1125-1133.
323. McDonald F.J., Price M.P., Snyder P.M., Welsh M.J. Cloning and expression of the β- and γ-subunits of the human epithelial sodium channel. Am J Physiol. 268:1995;C1157-C1163.
324. McDonnell D.P., Shahbaz M.M., Vegeto E., Goldman M.E. The human progesterone receptor A-form functions as a transcriptional modulator of mineralocorticoid receptor transcriptional activity. J Steroid Biochem Mol Biol. 48:1994;425-432.
325. McDonough A.A., Tang M.J., Lescale M.L. Ionic regulation of the biosynthesis of Na-K-ATPase subunits. Semin Nephrol. 10:1990;400-409.
326. +-ATPAse α- and β-subunits along rat nephron. isoform specificity and response to hypokalemia Am J Physiol. 267:1994;C901-C908.
327. + channels in fetal type II pneumocytes are regulated by G proteins. Am J Physiol. 267:1994;L1-L8.
328. Melby J.C. Endocrine hypertension. J Clin Endocrinol Metab. 69:1989;697-703.
329. Mellon S.H., Compagnone N., Sander M., Cover C., Ganten D., Djavidani B. Rodent models for studying steroids and hypertension. from fetal development to cells in culture Steroids. 60:1995;59-64.
330. Mengelsdorf D.J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R.M. The nuclear receptor superfamily. the second decade Cell. 83:1995;835-839.
331. Mesiano S., Jaffe R.B. Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev. 18:1997;378-403.
332. Meves H., Nagy K. Multiple conducting states of the sodium channel and of other ion channels. Biochim Biophys Acta. 988:1989;99-105.
333. Meyer C.J., Layne D.S., Tait J.F., Pincus G. The binding of aldosterone to plasma proteins in normal, pregnant, and steroid-treated women. J Clin Invest. 40:1961;1663-1671.
334. Meyer J.S. Biochemical effects of corticosteroids on neural tissue. Physiol Rev. 65:1985;946-1021.
335. Meyer M.E., Gronemeyer H., Turcotte B., Bocquel M.T., Tasset D., Chambon P. Steroid hormone receptors compete for factors that mediate their enhancer function. Cell. 57:1989;433-442.
336. Meyer W. Animal models of mineralocorticoid resistance. Adv Exp Biol Med. 196:1986;197-211.
337. Michaut P., Planes C., Escoubet B., Clement A., Amiel C., Clerici C. Rat lung alveolar type II cell line maintains sodium transport characteristics of primary culture. J Cell Physiol. 169:1996;78-86.
338. Miller J.W., Crapo L. The medical treatment of Cushing's syndrome. Endocr Rev. 14:1993;443-458.
339. Miller W.L. Molecular biology of steroid hormone synthesis. Endocr Rev. 9:1988;295-318.
340. +,ATPase inhibitor. Hypertension. 10:1987;157-160.
341. Mirshahi M., Mirshahi A., Nato A., Agarwal M.K. Receptor mediated mineralocorticoid action in alga cell mutants. FEBS Lett. 314:1992;237-240. a.
342. Mirshahi M., Mirshahi A., Nato A., Agarwal M.K. Mineralocorticoid hormone action in plant cells. Biochem Biophys Res Commun. 186:1992;1102-1107. b.
343. Mirshahi M., Pagano M., Mirshahi A., Agarwal M.K. Generation of polyclonal antibodies against the mineralocorticoid receptor and analysis of mineralocortin in rat myocardium by immunophotochemistry. Biochim Biophys Acta. 1120:1992;17-23. c.
344. Mirshahi M., Pagano M., Razaghi A., Lazar G., Agarwal M.K. Immunophotochemical analysis of mineralocortin by polyclonal antibodies against the native receptor from rat kidney. Biochem Med Metab Biol. 47:1992;133-144. d.
345. Mirshahi M., Nicolas C., Mirshahi A., Hecquet C., d'Hermies F., Faure J.P., Agarwal M.K. The mineralocorticoid hormone receptor and action in the eye. Biochem Biophys Res Commun. 219:1996;150-156.
346. Mirshahi M., Mirshahi A., Sedighian R., Hecquet C., Faure J.P., Agarwal M.K. Immunochemical demonstration of the mineralocorticoid receptor in ocular tissues. Neuroendocrinology. 65:1997;70-78.
347. Mirshahi M., Mirshahi S., Golestaneh N., Nicolas C., Mishal Z., Agarwal M.K. Mineralocorticoid hormone receptor and the epithelial sodium channel in a human leukemic cell line. Endocrine Res. 24:1998;455-459. a.
348. Mirshahi M., Nicolas C., Agarwal M.K. Enhanced activation of the mineralocorticoid receptor in genetically hypertensive rats. Biochem Biophys Res Commun. 244:1998;120-125. b.
349. Mirshahi M., Nicolas C., Mirshahi S., Golestaneh N., d'Hermies F., Agarwal M.K. Immunochemical analysis of the sodium channel in rodent and human eye. Exp Eye Res. 69:1999;21-32.
350. Miyahara K., Kawamoto T., Mitsuuchi Y., Toda K., Imura H., Gordon R.D., Shizuta Y. The chimeric gene linked to glucocorticoid-suppressible hyperaldosteronism encodes a fused P-450 protein possessing aldosterone synthase activity. Biochem Biophys Res Commun. 189:1992;885-891.
351. + channel-like immunoreactivity in the luminal membrane of some non-sensory epithelial cells of the inner ear. Hear Res. 88:1995;199-205.
352. Monder C. Corticosteroids, receptors, and the organ-specific functions of 11β-hydroxysteroid dehydrogenase. FASEB J. 5:1991;3047-3054.
353. + channels in membrane vesicles from intralobular salivary ducts. Am J Physiol. 268:1995;C350-C355.
354. Morohashi K. The ontogenesis of the steroidogenic tissues. Genes Cells. 2:1997;95-106.
355. Morris D.J. The role of steroid metabolism in protective and specificity conferring mechanisms of mineralocorticoid action. Vit Horm. 50:1995;461-485.
356. Moustaid N., Hainque B., Boulange A.Q., Agarwal M.K. Analysis of the glucocorticoid receptor during differentiation of 3T3-F4421 preadipocyte cell line in culture. Biochem Med Metab Biol. 43:1990;93-100.
357. + secretion by turtle urinary bladder J Clin Invest. 61:1978;1666-1670.
358. Muhn P., Fuhrmann U., Fritzmeier K.H., Krattenmacher R., Schillinger E. Drospirenone. a novel progestogen with antimineralocorticoid and antiandrogenic activity Ann N Y Acad Sci. 761:1995;311-335.
359. Muller J. Aldosterone. The minority hormone of the adrenal cortex Steroids. 60:1995;2-9.
360. Mune T., Rogesron F.M., Nikkila H., Agarwal A.K., White P.C. Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase. Nat Genet. 10:1995;394-399.
361. Murasawa S., Matsubara H., Kanasaki M., Kijima K., Maruyama K., Nio Y., Okubo N., Tsukaguchi H., Mori Y., Inada M. Characterization of glucocorticoid response element of rat angiotensin II type 1 receptor gene. Biochem Biophys Res Commun. 209:1995;832-840.
362. Murlow P.J., Takagi M., Saenz R.F. Inhibitors of aldosterone secretion. J Steroid Biochem. 27:1987;941-946.
363. Naylor P.H., Gilani S.S.H., Milholland R.J., Rosen F. Antiglucocorticoids. in vivo assay and evaluation of cortexolone, progesterone and 6 β-bromoprogesterone Endocrinology. 107:1980;117-121.
364. Negulyaev Y.A., Vedernikova E.A. Sodium-selective channels in membranes of rat macrophages. J Membr Biol. 138:1994;37-45.
365. Negulyaev Y.A., Vedernikova E.A., Mozhayeva G.N. Several types of sodium-conducting channel in human carcinoma 1-431 cells. Biochim Biophys Acta. 994:1994;171-175.
366. Nelson W.J., Hammerton R.W., McNeill H. Role of the membrane-cytoskeleton in the spatial organization of the Na,K-ATPase in polarized epithelial cells. Soc Gen Physiol Ser. 46:1991;77-87.
367. Nemere I., Carson M.C.F. Membrane receptors for steroid hormones. a case for specific cell surface binding sites for vitamin D metabolites and estrogens Biochem Biophys Res Commun. 248:1998;443-448.
368. New M.I. The prismatic case of apparent mineralocorticoid excess. J Clin Endocrinol Metab. 79:1994;1-3.
369. Nguyen T.T., Lazure C., Babinski K., Chretien M., Ong H., DeLean A. Aldosterone secretion inhibitory factor. a novel neuropeptide in bovine chromaffin cells Endocrinology. 124:1989;1591-1594.
370. Nichols N.R., Obert D.F., Meyer W.J. Comparison of aldosterone binding in aortic cells from DAHL salt-susceptible and salt-resistant rats. Life Sci. 36:1985;1653-1660.
371. Nishino Y., Schroder H., ElEtreby M.F. Experimental studies on the endocrine side effects of new aldosterone antagonists. Drug Res. 38:1988;1800-1805.
372. Noda M., Ikeda T., Suzuki H., Takeshima H., Takahashi T. Expression of functional sodium channels from cloned cDNA. Nature. 322:1986;826-828.
373. 2 gene encoding steroid 18-hydroxylase (P450C18). Biochem Biophys Res Commun. 232:1997;382-385.
374. Nonaka Y., Takemori H., Halder S.K., Sun T., Ohta M., Hatano O., Takakusu A., Okamoto M. Frog cytochrome P-450 (11beta,aldo), a single enzyme involved in the final steps of glucocorticoid and mineralocorticoid biosynthesis. Eur J Biochem. 229:1995;249-256.
375. Noone P.G., Knowles M.R. Trends in therapy of abnormal airway epithelial ion and liquid transport. Monaldi Arch Chest Dis. 48:1993;140-143.
376. O'Brodovich H., Hannam V., Seear M., Mullen J.B. Amiloride impairs lung water clearance in newborn guinea pigs. J Appl Physiol. 68:1990;1758-1762.
377. Oelkers W., Foidart J.M., Dombrovicz N., Welter A., Heithecker R. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-angiotensin system, body weight, blood pressure, glucose tolerance and lipid metabolism. J Clin Enodocrinol Metab. 80:1995;1816-1821.
378. Oh Y., Warnock D.G. Expression of the amiloride-sensitive sodium channel beta subunit gene in human B lymphocytes. J Am Soc Nephrol. 8:1997;126-129.
379. + channel in planary bilayers. Am J Physiol. 265:1993;C85-C91.
380. Okamoto M., Takemori H., Halder S.K., Hatano O. Zona glomerulosa-specific factor. cloning and function Steroids. 62:1997;73-76.
381. Okubo S., Niimura F., Nishimura H., Takemoto F., Fogo A., Matsusaka T., Ichikawa I. Angiotensin-independent mechanism for aldosterone synthesis during chronic extracellular fluid volume depletion. J Clin Invest. 99:1997;855-860.
382. Onate S.A., Tsai S.Y., Tsai M.J., O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science. 270:1995;1354-1355.
383. O'Neil R.G. Aldosterone regulation of sodium and potassium transport in the cortical collecting duct. Semin Nephrol. 10:1990;365-374.
384. Ono S., Hirano H., Obara K. Presence of cortisol-binding protein in the lens. Ophthalmic Res. 3:1972;233-234.
385. Opoku J., Kalimi M., Agarwal M.K., Qureshi D. Effect of a new mineralocorticoid antagonist mespirenone on aldosterone-induced hypertension. Am J Physiol. 260:1991;E269-E271.
386. Orser B.A., Bertlik M., Fedorko L., O'Brodovich H. Cation selective channel in fetal alveolar type II epithelium. Biochim Biophys Acta. 1094:1991;19-26.
387. + receptor mechanisms Chem Senses. 20:1995;37-46.
388. +-ATPase. A model of transmembrane arrangement. FEBS Lett. 217:1987;269-274.
389. Pacha J., Popp M., Capek K. Potassium secretion by neonatal rat distal colon. Pflügers Arch. 410:1987;362-368.
390. Pacha J., Frindt G., Antonian L., Silver R.B., Palmer L.G. Regulation of Na channels of the rat collecting tubule by aldosterone. J Gen Physiol. 102:1993;25-42.
391. Pagano M., Mirshahi M., Mirshahi F., Monnot M., Lazar G., Chassaing C.G., Fermandjian S., Agarwal M.K. Properties of the mineralocorticoid receptor immunopurified from bovine kidney. Biochem Pharmacol. 48:1994;1163-1169.
392. Palmer L.G. Epithelial sodium channels. function and diversity Annu Rev Physiol. 54:1992;51-66.
393. Panarelli M., Holloway C.D., Barr A.B.P., Raser R.F., Kenyon C.J. Differences in temperature-sensitive receptor binding of glucocorticoids in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Steroids. 60:1995;73-75.
394. Parker K.L., Schimmer B.P. Steroidogenic factor I. a key determinant of endocrine development and function Endocr Rev. 18:1997;361-377.
395. Parker M.G., White R. Nuclear receptors spring into action. Nature Struct Biol. 3:1996;113-115.
396. Partridge L.D., Swandulla D. Calcium-activated non-specific cation channels. Trends Neurosci. 11:1988;69-72.
397. Pascoe L., Curnow K.M. Genetic recombination as a cause of inherited disorders of aldosterone and cortisol biosynthesis and a contributor to genetic variation in blood pressure. Steroids. 60:1995;22-27.
398. Pasternak C.A. Membrane transport and disease. Mol Cell Biochem. 91:1989;3-11.
399. Patel P.D., Sherman T.G., Goldman D.J., Watson S.J. Molecular cloning of a mineralocorticoid (Type I) complementary DNA from rat hippocampus. Mol Endocrinol. 3:1989;1877-1885.
400. + channels. Physiol Rev. 71:1991;1047-1080.
401. Pearce D., Yamamoto K.R. Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science. 259:1993;1161-1165.
402. Pedemonte C.H., Kaplan J.H. Chemical modification as an approach to elucidation of sodium pump structure-function relations. Am J Physiol. 258:1990;C1-C23.
403. Penning T.R. Molecular endocrinology of hydroxysteroid dehydrogenases. Endocr Rev. 18:1997;281-305.
404. Pessina A.C., Sacchetto A., Rossi G.P. Left ventricular anatomy and function in primary aldosteronism and renovascular hypertension. Adv Exp Med Biol. 432:1997;63-69.
405. Peter M., Fawaz L., Drop S.L., Visser H.K., Sippell W.G. Hereditary defect in biosynthesis of aldosterone. aldosterone synthase deficiency J Clin Endocrinol Metab. 82:1997;3525-3528.
406. Peter M., Viemann M., Partsch C.J., Sippell W.G. Congenital adrenal hypoplasia. clinical spectrum, experience with normal diagnosis, and report on new point mutations of the DAX-1 gene J Clin Endocrinol Metab. 83:1998;2666-2774.
407. Peterson R.E. Plasma corticosterone and hydrocortisone levels in man. J
408. Peterson R.E. Adrenal cortical steroid metabolism and adrenal cortical function in liver disease. J Clin Invest. 39:1960;320-331.
409. ++-regulated expression of aldosterone synthase is mediated by calmodulin and calmodulin-dependent protein kinases. Endocrinology. 138:1997;835-839.
410. Picard D., Salser S.J., Yamamoto K.R. A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor. Cell. 54:1988;1073-1078.
411. Pieri C., Reccchioni R., Moroni F., Balkay L., Marian T., Tron L., Damjanovich S. Ligand and voltage gated sodium channels may regulate electrogenic pump activity in human, mouse and rat lymphocytes. Biochem Biophys Res Commun. 160:1989;999-1002.
412. Pincus G. The biosynthesis of adrenal cortical steroids. J Clin Endocrinol Metab. 3:1943;195-199.
413. Pollack S.E., Furth E.E., Kallen C.B., Arakane F., Kiriakidou M., Kozarsky K.F., Strauss J.E. Localization of the steroidogenic acute regulatory protein in human tissues. J Clin Endocrinol Metab. 82:1997;4243-4251.
414. Pollow K., Juchem M., Grill H.J., Elger W., Beier S., Henderson D., Schmidt G.K., Manz B. Gestodene. a novel synthetic progestin - characterization of binding to receptor and serum proteins Contraception. 40:1989;325-341.
415. Post R.L. Seeds of sodium, potassium ATPase. Annu Rev Physiol. 51:1989;1-15.
416. Postnov Y.V., Orlov S.N. Ion transport across plasma membrane in essential hypertension. Physiol. Rev. 65:1985;904-945.
417. Prat A.G., Bertorello A.M., Ausiello D.A., Cantiello H.F. Activation of epithelial sodium channels by protein kinase A requires actin filaments. Am J Physiol. 265:1993;C224-C233.
418. + channel. J Biol Chem. 271:1996;18045-18053.
419. Pratt W.B., Toft D.O. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev. 18:1997;306-359.
420. Prenti P., Villa M., Hanozet G.M., Ferrandi M., Ferrari P. Increased Na pump activity in the kidney cortex of the Milan hypertensive rat strain. FEBS Lett. 290:1991;200-204.
421. +-ATPase expression. Semin Nephrol. 12:1992;67-71.
422. Quinn R.H., Miller S.S. Ion transport mechanisms in native human retinal pigment epithelium. Invest Ophthalmol Vis Sci. 33:1992;3513-3537.
423. Quinton P.M. Cystic fibrosis. a disease in electrolyte transport FASEB J. 4:1990;2709-2717.
424. +-ATPase in hypertension. Semin Nephrol. 12:1992;72-75.
425. + channel in colon, lung and kidney. Pflügers Arch. 430:1995;299-307.
426. Repke K.R., Sweadner K.J., Weiland J., Megges R., Schon R. In search of ideal ionotropic steroids. Rec Prog Drug Res. 47:1996;9-52.
427. Reul J.M.H.M., DeKloet E.R., VanSluijs F.J., Rijnberk A., Rothuizen J. Binding characteristics of mineralocorticoid and glucocorticoid receptors in dog brain and pituitary. Endocrinology. 127:1990;907-915.
428. Revelli A., Massobrio M., Tesarik J. Nongenomic effects of steroid hormones in reproductive tissues. Endocr Rev. 19:1998;3-17.
429. Robertson N.M., Schulman G., Karnik S., Alnemri E., Litwack G. Demonstration of nuclear translocation of the mineralocorticoid receptor (MR) using an anti-MR antibody and confocal laser scanning microscopy. Mol Endocrinol. 7:1993;1226-1239.
430. Robles R.G., Ruilope L.M. Pharmacological influences on aldosterone secretion. J Steroid Biochem. 27:1987;947-951.
431. +-ATPase in the rat by adrenal steroids. Am J Physiol. 10:1981;F186-F195.
432. Rondinone C.M., Rodbard D., Baker M.E. Aldosterone stimulates differentiation of mouse 3T3-L1 cells into adipocytes. Endocrinology. 132:1993;2421-2426.
433. Rose A.M., Valdes R.J. Understanding the sodium pump and its relevance to disease. Clin Chem. 40:1994;1674-1685.
434. Rossier B.C., Canessa C.M., Schild L., Horisberger J.D. Epithelial sodium channels. Curr Opin Nephrol Hypertens. 3:1994;487-496.
435. Rossier M.F. Confinement of intracellular calcium signalling in secretory and steroidogenic cells. Eur J Endocrinol. 137:1997;317-325.
436. + transport in isolated rat CCD. effects of bradykinin, ANP, clonidine, and hydrocloro-thiazide Am J Physiol. 260:1991;F86-F95.
437. Rozsival P., Hampl R., Obenberger J., Starka L., Rehak S. Aqueous humour and plasma cortisol in glaucoma and cataract patients. Curr Eye Res. 1:1981;391-396.
438. Rupprecht R., Arrizza J.L., Spengler D., Reul J.M.H.M., Evans R., Damm K. Transactivation and synergistic properties of the mineralocorticoid receptor. relationship to the glucocorticoid receptor Mol Endocrinol. 7:1993;597-603.
439. Rusch A., Kros C.J., Richardson G.P. Block by amiloride and its derivatives of mecano-electrical transduction in outer hair cells of mouse cochlear cultures. J Physiol. 474:1994;75-86.
440. Sakauye C., Feldman D. Agonist and antimineralocorticoid activites of spirolactones. Am J Physiol. 231:1976;93-97.
441. Sandberg A.A., Slaunwhite W.R., Carter A.C. Transcortin. a corticosteroid binding protein of plasma. III. The effects of various steroids J Clin Invest. 39:1960;1914-1926.
442. Sandle G.I., Binder H.J. Corticosteroids and intestinal ion transport. Gastroenterology. 93:1987;188-196.
443. Sandor T.A. Comparative survey of steroids and steroidogenic pathways throughout the vertebrates. Gen Comp Endocrinol. 2(suppl.):1969;284-298.
444. Sandor T.A., Mehdi A.Z. Steroids and evolution. Barrington E.J.W. Hormones and Evolution. 1970;2-72 Academic Press, New York, San Francisco, Oxford.
445. + permeability in epithelia Kidney Int. 48:1995;965-969.
446. Sato A., Suzuki H., Murakami M. Glucocorticoid increases angiotensin II type I receptor and its gene expression. Hypertension. 23:1994;25-30.
447. Satoh M., Shimura S., Sasaki T., Yamamoto M., Takishima T., Shirato K. Magnesium regulates ion transport across canine tracheal epithelium. Respir Physiol. 96:1994;321-326.
448. Sauer M., Flemner A., Thurau K., Beck F.X. Sodium entry routes in principal and intercalated cells of the isolated perfused cortical collecting duct. Pflügers Arch. 416:1990;88-93.
449. Sayers G., Sayers M. The pituitary-adrenal system. Recent Prog Horm Res. 2:1948;81-116.
450. Scarpa A., Carafoli E. Calcium transport and cell function. Ann N Y Acad Sci. 307:1978;1-655.
451. + channels in the cortical collecting duct by AVP and mineralocorticoids. Kidney Int. 41:1992;255-268.
452. Schambelan M., Biglieri E.G. Deoxycorticosterone production and regulation in man. J Clin Endocrinol Metab. 34:1972;695-703.
453. Scheibel T., Buchner J. The Hsp90 complex - a super-chaperone machine as a novel drug target. Biochem Pharmacol. 56:1998;675-682.
454. Schiffman S.S., Fray A.E., Suggs M.S., Cragoe E.J., Erickson R.P. The effect of amiloride analogs on taste response in gerbil. Physiol Behav. 47:1990;435-441.
455. Schild L., Canessa C.M., Shimkets R.A., Gautschi I., Lifton R.P., Rossier B.C. A mutation in the epithelial sodium channel causing Liddle disease increases channel activity in the Xenopus laevis oocyte expression system. Proc Natl Acad Sci USA. 92:1995;5699-5703.
456. +-ATPase isoforms in the retina. Int Rev Cytol. 133:1992;151-185.
457. 3H-aldosterone in vitro. Res Exp Med. 171:1977;57-62.
458. Schultz S.G. A century of (epithelial) transport physiology. from vitalism to molecular cloning Am J Physiol. 274(Cell Physiol 43):1998;C13-C23.
459. Schuster V.L. Function and regulation of collecting duct intercalated cells. Annu Rev Physiol. 55:1993;267-288.
460. Schwartz B., Wysocki A. Mineralocorticoid receptors in the rabbit iris-ciliary body. Ophthalmic Res. 29:1997;42-47.
461. Scoggins B.A., Coghlan J.P., Denton D.A. Understanding the mechanism of adrenocortical steroid hypertension. J Steroid Biochem. 32:1989;205-208.
462. Scott B.A., Lawrence B., Nguyen H.H., Meyer W.J. Aldosterone and dexamethasone binding in human arterial smooth muscle cells. J Hypertens. 5:1987;739-744.
463. Sear J.W., Edwards C.R., Atherden S.M. Dual effects of etomidate on mineralocorticoid biosynthesis. Acta Anaesthesiol Belg. 39:1988;87-94.
464. Seckl J.R., Dickson K.L., Yates C., Fink G. Distribution of glucocorticoid and mineralocorticoid receptor messenger RNA expression in human postmortem hippocampus. Brain Res. 561:1991;332-337.
465. Sekihara H., Yazaki Y., Kojima T. Ouabain as an amplifier of mineralocorticoid-induced hypertension. Endocrinology. 131:1992;3077-3082.
466. Semplicini A., Serena L., Vale R., Ceolotto G., Felice M., Fontebasso A., Pessina A.C. Ouabain-inhibiting activity of aldosterone antagonists. Steroids. 60:1995;110-113.
467. Shibata H., Spencer T.E., Onate S.A., Jenster G., Tsai S.Y., Tsai M.J., O'Malley B.W. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Rec Prog Horm Res. 52:1997;141-166.
468. Shimada T., Yasuda K., Mori A., Ni H., Asis L.B.M., Murase H., Miura K. Aldosterone binding to mineralocorticoid receptors of mononuclear leukocytes in diabetic subjects. Acta Endocrinol. 128:1993;529-535.
469. Shimkets R.A., Warnock D.G., Bositis C.M., Williams C.N., Hansson J.H., Schambelan M., Gill J.R., Ulick S., Milora R.V., Findling J.W., Canessa C.M., Rossier B.C., Lifton R.P. Liddle's syndrome. heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel Cell. 79:1994;407-414.
470. Shimkets R.A., Lifton R.P., Canessa C.M. The activity of the epithelial sodium channel is regulated by clathrin-mediated endocytosis. J Biol Chem. 272:1997;25537-25541.
471. Shimkets R.A., Lifton R., Canessa C.M. In vivo phosphorylation of the epithelial sodium channel. Proc Natl Acad Sci USA. 95:1998;3301-3305.
472. Shizuta Y., Kawamoto T., Mitsuuchi Y., Miyahara K., Rösler A., Ulick S., Imura H. Inborn errors of aldosterone biosynthesis in humans. Steroids. 60:1995;15-21.
473. Siemen D., Hescheler J. Nonselective Cation Channels. Pharmacology, Physiology and Biophysics:1993;Birkhauser Verlag, Basel.
474. Skadhauge E. Osmoregulation in Birds. 1981;Springer-Verlag, New York.
475. Smith P., Rhodes N.P., Shortland A.P., Fraser S.P., Djamgoz M.B.A., Ke Y., Foster C.S. Sodium channel protein expression enhances the invasiveness of rat and human prostate cancer. FEBS Lett. 423:1998;19-24.
476. Smith P.R., Saccomani G., Joe E.H., Angelides K.J., Benos D.J. Amiloride-sensitive sodium channel is linked to the cytoskeleton in renal epithelial cells. Proc Natl Acad Sci USA. 88:1991;6971-6975.
477. Snart R.S., Taylor E. Aldosterone effects on renal metabolism. J Physiol. 274:1978;447-454.
478. Snyder P.M., McDonald F.J., Stokes J.B., Welsh M.J. Membrane topology of the amiloride-sensitive epithelial sodium channel. J Biol Chem. 269:1994;24379-24383.
479. + channel. Cell. 83:1995;969-978.
480. Soffer L.J., Dorfman R.I., Gabrilov J.L. The Human Adrenal Gland. 1961;Lea & Febiger, Philadelphia.
481. + permeability in epithelia Kidney Int. 48:1995;965-969.
482. Southern A.L., Gordon G.G., Yeh H.S., Dunn M.W., Weinstein B.I. Receptors for glucocorticoids in the lens epithelium of the calf. Science. 200:1978;1177-1178.
483. Speiser P.W., Riddick L.M., Martin K., New M.I. Investigation of the mechanism of hypertension in apparent mineralocorticoid excess. Metabolism. 42:1993;843-845.
484. Stanton B.A., Kaissling B. Regulation of renal ion transport and cell growth by sodium. Am J Physiol. 257:1989;F1-F10.
485. Starka L., Hampl R., Obenberger I.J. Aldosterone binding in bovine ciliary body. Endocrinol Exp. 11:1977;203-208.
486. Starka L., Hampl R., Obenberger I.J., Doskocil M. The role of corticosteroids in the homeostasis of the eye. J Steroid Biochem. 24:1986;199-205.
487. Staub O., Verrey F., Kleyman T.R., Benos D.J., Rossier B.C., Kraehenbuhl J.P. Primary structure of an apical protein from Xenopus laevis that participates in amiloride-sensitive sodium channel activity. J Cell Biol. 119:1992;1497-1506.
488. Staub O., Gautschi I., Ishikawa T., Breitschopf K., Ciechanover A., Schild L., Rotin D. Regulation of stability and function of the epithelial Na+ channel (ENaC) by ubiquitination. EMBO J. 16:1997;6325-6336.
489. Steinmetz P.R. Cellular mechanisms of urinary acidification. Physiol Rev. 54:1974;890-956.
490. Stewart P.M. Cortisol, hypertension and obesity. the role of 11 β-hydroxysteroid dehydrogenase J R Coll Physicians Lond. 32:1998;154-158.
491. Stocco D.M., Clark B.J. The role of the steroidogenic acute regulatory protein in steroidogenesis. Steroids. 62:1997;29-36.
492. Stokes J.B., Sigmund R.D. Regulation of rENaC mRNA by dietary NaCl and steroids. organ, tissue, and steroid specificity Am J Physiol. 274(Cell Physiol 43):1998;C1699-C1707.
493. Stone D.K., Crider B.P., Xie X.S. Aldosterone and urinary acidification. Semin Nephrol. 10:1990;375-379.
494. Strautnieks S.S., Thompson R.J., Gardiner R.M., Chung E. A novel splice-site mutation in the γ-subunit of the sodium channel gene in three pseudohypoaldosteronism type 1 families. Nat Genet. 13:1996;248-250. a.
495. Strautnieks S.S., Thompson R.J., Hanukoglu A., Dillon M.J., Hanukoglu I., Kuhnle U., Seckl J., Gardiner R.M., Chung E. Localisation of pseudohypoaldosteronism genes to chromosome 16p 12.2-13.11 and 12p 13.1-pter by homozygous mapping. Hum Mol Genet. 5:1996;293-299. b.
496. Stutts M.J., Canessa C.M., Olsen J.C., Hamrick M., Cohn J.A., Rossier B.C., Boucher R.C. CFTR as a cAMP-dependent regulator of sodium channels. Science. 269:1995;847-850.
497. Sulon J., Vliers M.P., Genard P., Cittanova N., Desfosses B. Radioimmunoassay for aldosterone and deoxycorticosterone in human plasma. Comparison of different antisera and determination of normal values. Biochem Biophys Acta. 72:1976;275-284.
498. Sutanto W., DeKloet E.R. Mineralocorticoid receptor ligands. Biochemical, pharmacological and clinical aspects Med Res Rev. 11:1991;617-639.
499. Suzuki H., Shibata H., Maruyama T., Ishimura Y., Saruta T. Significance of steroidogenic enzymes in the pathogenesis of hyperfunctioning and non-hyperfunctioning adrenal tumor. Steroids. 60:1995;42-47.
500. +-ATPase. Biochim Biophys Acta. 988:1989;185-220.
501. + conductance by acetylcholine in rabbit cortical collecting duct perfused in vitro. J Clin Invest. 93:1994;2649-2657.
502. Takeda R., Hatakeyama H., Takeda Y. Aldosterone biosynthesis and action in vascular cells. Steroids. 60:1995;120-124.
503. Takeda Y., Miyamori I., Takeda R. Significance of 19-noraldosterone, a new mineralocorticoid, in clinical and experimental hypertension. Steroids. 60:1995;137-142.
504. Tamura H., Schild L., Enomoto N. Liddle disease caused by a missense mutation of the β subunit of the epithelial sodium channel causes hypertension and Liddle syndrome and identifies a proline-rich segment of the protein critical for regulation of channel activity. Proc Natl Acad Sci USA. 92:1995;11495-11499.
505. Taub R., Greene M.I. Functional validation of ligand mimicry by antireceptor antibodies. structural and therapeutic implications Biochemistry. 31:1992;7431-7435.
506. Taylor A., Windhager E.E. Possible role of cytosolic calcium and Na-Ca exchange in regulation of transepithelial sodium transport. Am J Physiol. 236:1979;F505-F512.
507. Tousson A., Alley C.D., Sorscher E.J., Brinkley B.R., Benos D.J. Immunocytochemical localization of amiloride-sensitive sodium channels in sodium-transporting epithelia. J Cell Sci. 93:1989;349-362.
508. +-activated ATPase. Curr Top Cell Regul. 19:1981;159-217.
509. Tsai R., Morris D. The effect of spironolactone on the hepatic metabolism of aldosterone in male rats. Endocrinology. 103:1987;1239-1244.
510. Turla K.M.T., Schnermann J., Toth G.F., Toth A., Smart N.A., Killen P.D., Briggs J.P. Distribution of mineralocorticoid and glucocorticoid receptor mRNA along the nephron. Am J Physiol. 264:1993;F781-F791.
511. Turnamian S.G., Binder H.J. Aldosterone and glucocorticoid receptor-specific agonists regulate ion transport in rat proximal colon. Am J Physiol. 258:1990;G492-G498.
512. Ulick S. Cortisol as a mineralocorticoid. J Clin Endocrinol Metab. 81:1996;1307-1308.
513. Ulick S., Tedde R., Mantero F. Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab. 70:1990;200-206.
514. Ulick S., Wand J.Z., Blumenfeld J.D., Pickering T.G. Cortisol inactivation overload. a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome J Clin Endocrinol Metab. 74:1992;963-967.
515. Ussing H.H., Zerahn K. Active transport of sodium as the source of electric current in the short-circuited isolated frog skin. Acta Physiol Scand. 23:1951;116-127.
516. +-ATPase in the epithelium of the rabbit ciliary body pars plicata. Invest Ophthalmol Vis Sci. 29:1988;606-614.
517. Vallee S.M., Grillo C.A., Gonzalez S. Further studies in deoxycorticosterone acetate treated rats. brain content of mineralocorticoid and glucocorticoid receptors and effect of steroid antagonists on salt intake Neuroendocrinology. 61:1995;117-124.
518. Vallet V., Chraibi A., Gaeggeler H.P., Horisberger J.D., Rossier B.C. An epithelial serine protease activates the amiloride-sensitive sodium channel. Nature. 389:1997;607-610.
519. van den Berg D.T.W.M., DeKloet E.R., VanDjiken H.H., DeJong W.W. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure. Endocrinology. 126:1990;118-124.
520. Van Driessche W., Zeiske W. Ionic channels in epithelial cell membranes. Physiol Rev. 65:1985;833-903.
521. VanEekelan J.A.M., Bohn M.C., DeKloet E.R. Postnatal ontogeny of mineralocorticoid and glucocorticoid receptor gene expression in regions of rat tele- and diencephalon. Dev Brain Res. 61:1991;33-43.
522. van Uum S.H., Hermus A.R., Smits P., Thein T., Lenders J.W. The role of 11 β-hydroxysteroid dehydrogenase in the pathogenesis of hypertension. Cardiovasc Res. 38:1998;16-24.
523. Vargish T., Shircliffe A., James P.M. Effects of steroids on cardiac function. Am Surg. 71:1974;688-696.
524. +/ATPase. Biochim Biophys Acta. 1154:1993;201-222.
525. Vazquez D.M., Lopez J.F., Morano M.I., Kwap S.P., Watson S.J., Akil H. Alpha, beta, and gamma mineralocorticoid receptor messenger ribonucleic acid splice variants. Differential expression and rapid regulation in the developing hippocampus Endocrinology. 139:1998;3165-3177.
526. Vegeto E., Allan G.F., Schrader W.T., Tsai M.J., McDonnell D.P., O'Malley B.W. Mechanisms of RU 486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell. 69:1992;703-713.
527. Vehaskari V.M., Hempe J.M., Manning J., Aviles D.H., Carmichael M.C. Developmental regulation of ENaC subunit mRNA levels in rat kidney. Am J Physiol. 274(Cell Physiol 43):1998;C1661-C1666.
528. Veldhuis J., Melby J.C. Isolated aldosterone deficiency in man. Acquired and inborn errors in the biosynthesis or action of aldosterone Endocr Rev. 2:1981;495-517.
529. Vilsen B. Leucine 332 at the boundary between the fourth transmembrane segment and the cytoplasmic domain of Na+,K+,ATPase plays a pivotal role in the ion translocating conformational change. Biochemistry. 36:1997;13312-13324.
530. + channel. Biophysical properties, pharmacology, ontogenesis, and molecular cloning Proc Natl Acad Sci USA. 91:1994;247-251.
531. + channel in the apical membrane of the rat renal inner medullary collecting duct. J Clin Invest. 96:1995;2748-2757.
532. Wacker J., Mistry N.E., Bauer H., Vecsei P., Stolz W., Bastert G. Mineralocorticoids and mineralocorticoid receptors in mononuclear leukocytes in patients with pregnancy-induced hypertension. Endocrinology. 74:1992;910-913.
533. Waeber B., Nussberger J., Brenner H.R. Clinical applications of antimineralocorticoids. J Steroid Biochem. 31:1988;739-744.
534. Waitzman M.B. Aldosterone and aqueous humor dynamics. Acta Ophthalmol. 41:1963;111-119.
535. + exchangers. Physiol Rev. 77:1997;51-74.
536. Walker B.R. Organ-specific actions of 11 β-hydroxysteroid dehydrogenase in humans. implications for the pathophysiology of hypertension Steroids. 59:1994;84-89.
537. Walton K.G., DeLorenzo R.J., Curran P.F., Greengard P. Regulation of protein phosphorylation and sodium transport in toad bladder. J Gen Physiol. 65:1975;153-177.
538. Wambach G., Helber A. Structure-activity relationship of antimineralocorticoid active steroids. Agarwal M.K. Hormone Antagonists. 1982;293-306 Walter de Gruyter, Berlin.
539. Wambach G., Higgins J.R. Antimineralocorticoid action of progesterone. Agarwal M.K. Antihormones. 1979;167-180 Elsevier/North Holland, Amsterdam.
540. Wambach G., Stenzel J.C. Structure activity relationship of spironolactone derivatives. Agarwal M.K. Adrenal Steroid Antagonism. 1984;291-313 Walter de Gruyter, Berlin.
541. + channels. structure and function Annu Rev Physiol. 59:1997;413-436.
542. Wang Z.M., Yasui M., Celsi G. Differential effects of glucocorticoids and mineralocorticoids on the mRNA expression of colon ion transporters in infant rats. Pediatr Res. 38:1995;164-168.
543. Warnock D.G., Bubien J.K. Liddle syndrome. clinical and cellular abnormalities Hosp Pract. 29:1994;95-98.
544. + channels of hen lower intestine in Xenopus oocytes. Biochim Biophys Acta. 1111:1992;159-164.
545. + transport across leech skin. Am J Physiol. 268:1995;R605-R613.
546. Wehling M. Specific, nongenomic actions of steroid hormones. Annu Rev Physiol. 59:1997;365-393.
547. Weinberger M.H. Mineralocorticoids and blood pressure. Curr Opin Nephrol Hypertens. 3:1994;550-553.
548. - cotransport in osteoblasts. Am J Physiol. 261:1991;C433-C440.
549. White P.C. Inherited forms of mineralocorticoid hypertension. Hypertension. 28:1996;927-936.
550. White P.C., Mune T., Agarwal A.K. 11β-Hydroxysteroid-dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev. 18:1997;135-156.
551. Whitworth J.A. Studies on the mechanism of glucocorticoid hypertension in humans. Blood Press. 3:1994;24-32.
552. Wickman K.D., Clapham D.E. G-protein regulation of ion channels. Curr Opin Neurobiol. 5:1995;278-285.
553. Wiesmann W.P., Johnson J.P., Miura G.A., Chiang P.K. Aldosterone-stimulated transmethylations are linked to sodium transport. Am J Physiol. 248:1985;F43-F47.
554. Winters J., Shackleton C.H.L., O'Rourke S.S., Bokkenheuser V.D. Bacterial formation of aldosterone metabolites. J Steroid Biochem. 21:1984;563-569.
555. Wong M., Ikeda Y., Luo X., Caron K.M., Weber T.J., Swain A., Schimmer B.P., Parker K.L. Steroidogenic factor 1 plays multiple roles in endocrine development and function. Rec Prog Horm Res. 52:1997;167-182.
556. Worcel M., Moura A.M. Arterial effects of aldosterone and antimineralocorticoid compounds. Mechanism of action J Steroid Biochem. 27:1987;4-6.
557. Yamakawa M., Ezumi K., Shiro M., Nakai H., Kamata S., Matsuji T., Haga N. Relationship of the molecular structure of aldosterone derivatives with their binding affinity for mineralocorticoid receptor. Mol Pharmacol. 30:1987;585-598.
558. Yamamoto K.R., Alberts B.M. Steroid receptors. elements for modulation of eukaryotic transcription Annu Rev Biochem. 45:1976;722-746.
559. Yamamoto K., Ikeda U., Seino Y., Tsuruya Y., Oguchi A., Okada K., Ishikawa S., Saito T., Kawakami K., Hara Y., Shimada K. Regulation of Na,K-ATPase gene expression by sodium ions in cultured neonatal cardiocytes. J Clin Invest. 92:1993;1889-1895.
560. Yasuda G., Shionoiri H., Hayashi S., Umemura S., Ikeda Y., Ishii M. Cushing's disease. evaluation of mineralocorticoid-induced hypertension Intern Med. 32:1993;784-788.
561. Yates F.E., Urquhart J. Control of plasma concentrations of adrenocortical hormones. Physiol Rev. 42:1962;359-443.
562. Young E.A., Lopez J.F., Weinberg V.M., Watson S.J., Akil H. The role of mineralocorticoid receptors in hypothalamic-pituitary-adrenal axis regulation in humans. Endocrinology. 83:1998;3339-3345.
563. Zazopoulos E., Lalli E., Stocco D.M., Corsi P.S. DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature. 390:1997;311-315.
564. Zicha J. Red cell ion transport abnormalities in experimental hypertension. Fundam Clin Pharmacol. 7:1993;129-141.